A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells

Vaccine

Volumn 27, Issue 2, 2009, Pages 213-222

  Bonafé, Nathalie ^a   Rininger, Joseph A ^b   Chubet, Richard G ^b   Foellmer, Harald G ^c   Fader, Stacey ^a   Anderson, John F ^d   Bushmich, Sandra L ^e   Anthony, Karen ^a   Ledizet, Michel ^a   Fikrig, Erol ^c   Koski, Raymond A ^a   Kaplan, Paul ^a  

^a L2 Diagnostics LLC   (United States)

^b Protein Sciences Corp   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Connecticut Agricultural Experiment Station ^*  (United States)

^e UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Baculovirus; Envelope protein; ExpresSF+ insect cells; Vaccine; West Nile virus

Indexed keywords

ALUMINUM HYDROXIDE; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; VIRUS ENVELOPE PROTEIN; WEST NILE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DENSITOMETRY; DROSOPHILA; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERMENTATION; HAMSTER; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREACTIVITY; INSECT CELL; LEPIDOPTERA; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUALITY CONTROL; RAT; SINGLE DRUG DOSE; TREATMENT RESPONSE; VACCINATION; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELLS, CULTURED; CRICETINAE; DISEASE MODELS, ANIMAL; HORSE DISEASES; HORSES; HUMANS; MICE; RATS; RECOMBINANT PROTEINS; SPODOPTERA; VIRAL ENVELOPE PROTEINS; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 57149084450     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.046     Document Type: Article

References (40)

1. Marfin A.A., and Gubler D.J. West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis 33 10 (2001) 1713-1719
2. Campbell G.L., Marfin A.A., Lanciotti R.S., and Gubler D.J. West Nile virus. Lancet Infect Dis 2 9 (2002) 519-529
3. Gould L.H., and Fikrig E. West Nile virus: a growing concern?. J Clin Invest 113 8 (2004) 1102-1107
4. Dauphin G., and Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 25 30 (2007) 5563-5576
5. Ng T., Hathaway D., Jennings N., Champ D., Chiang Y.W., and Chu H.J. Equine vaccine for West Nile virus. Dev Biol (Basel) 114 (2003) 221-227
6. Grosenbaugh D.A., Backus C.S., Karaca K., Minke J.M., and Nordgren R.M. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine. Vet Ther 5 4 (2004) 251-257
7. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 75 9 (2001) 4040-4047
8. Martin J.E., Pierson T.C., Hubka S., Rucker S., Gordon I.J., Enama M.E., et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J Infect Dis 196 12 (2007) 1732-1740
9. Arroyo J., Miller C., Catalan J., Myers G.A., Ratterree M.S., Trent D.W., et al. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 78 22 (2004) 12497-12507
10. Monath T.P., Liu J., Kanesa-Thasan N., Myers G.A., Nichols R., Deary A., et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci USA 103 17 (2006) 6694-6699
11. Pletnev A.G., Claire M.S., Elkins R., Speicher J., Murphy B.R., and Chanock R.M. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 314 1 (2003) 190-195
12. Pletnev A.G., Swayne D.E., Speicher J., Rumyantsev A.A., and Murphy B.R. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 24 40-41 (2006) 6392-6404
13. Despres P., Combredet C., Frenkiel M.P., Lorin C., Brahic M., and Tangy F. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis 191 2 (2005) 207-214
14. Iglesias M.C., Frenkiel M.P., Mollier K., Souque P., Despres P., and Charneau P. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. J Gene Med 8 3 (2006) 265-274
15. Wang T., Anderson J.F., Magnarelli L.A., Wong S.J., Koski R.A., and Fikrig E. Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol 167 9 (2001) 5273-5277
16. Ledizet M., Kar K., Foellmer H.G., Wang T., Bushmich S.L., Anderson J.F., et al. A recombinant envelope protein vaccine against West Nile virus. Vaccine (2005) 3915-3924
17. Watts D.M., Tesh R.B., Siirin M., Rosa A.T., Newman P.C., Clements D.E., et al. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine 25 15 (2007) 2913-2918
18. Lieberman M.M., Clements D.E., Ogata S., Wang G., Corpuz G., Wong T., et al. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine 25 3 (2007) 414-423
19. Qiao M., Ashok M., Bernard K.A., Palacios G., Zhou Z.H., Lipkin W.I., et al. Induction of sterilizing immunity against West Nile virus (WNV), by immunization with WNV-like particles produced in insect cells. J Infect Dis 190 12 (2004) 2104-2108
20. Chu J.H., Chiang C.C., and Ng M.L. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J Immunol 178 5 (2007) 2699-2705
21. Martina B.E., Koraka P., van den Doel P., van Amerongen G., Rimmelzwaan G.F., and Osterhaus A.D. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 26 2 (2008) 153-157
22. McDonald W.F., Huleatt J.W., Foellmer H.G., Hewitt D., Tang J., Desai P., et al. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 195 11 (2007) 1607-1617
23. Kanai R., Kar K., Anthony K., Gould L.H., Ledizet M., Fikrig E., et al. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80 22 (2006) 11000-11008
24. Anderson J.F., Andreadis T.G., Vossbrinck C.R., Tirrell S., Wakem E.M., French R.A., et al. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 286 5448 (1999) 2331-2333
25. Ledizet M., Kar K., Foellmer H.G., Bonafe N., Anthony K.G., Gould L.H., et al. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus. J Infect Dis 196 12 (2007) 1741-1748
26. In: Beaty B.J., Calisher C.H., and Shope R.E. (Eds). Arboviruses. 6th ed. (1989), American Public Health Association, Washington, DC
27. Durbin A.P., Karron R.A., Sun W., Vaughn D.W., Reynolds M.J., Perreault J.R., et al. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am J Trop Med Hyg 65 5 (2001) 405-413
28. Goncalvez A.P., Men R., Wernly C., Purcell R.H., and Lai C.J. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses. J Virol 78 23 (2004) 12910-12918
29. Pletnev A.G., Putnak R., Speicher J., Wagar E.J., and Vaughn D.W. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci USA 99 5 (2002) 3036-3041
30. Lindblad E.B. Aluminium compounds for use in vaccines. Immunol Cell Biol 82 5 (2004) 497-505
31. Wong S.J., Demarest V.L., Boyle R.H., Wang T., Ledizet M., Kar K., et al. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42 1 (2004) 65-72
32. Xiao S.Y., Guzman H., Zhang H., Travassos da Rosa A.P., and Tesh R.B. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 7 4 (2001) 714-721
33. Treanor J.J., Schiff G.M., Hayden F.G., Brady R.C., Hay C.M., Meyer A.L., et al. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA 297 14 (2007) 1577-1582
34. Putnak R.J., Coller B.A., Voss G., Vaughn D.W., Clements D., Peters I., et al. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine 23 35 (2005) 4442-4452
35. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 6972 (2004) 313-319
36. van Oers M.M. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv Virus Res 68 (2006) 193-253
37. Putnak R., Feighny R., Burrous J., Cochran M., Hackett C., Smith G., et al. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. Am J Trop Med Hyg 45 2 (1991) 159-167
38. Delenda C., Frenkiel M.P., and Deubel V. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Arch Virol 139 1-2 (1994) 197-207
39. Nybakken G.E., Nelson C.A., Chen B.R., Diamond M.S., and Fremont D.H. Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80 23 (2006) 11467-11474
40. Li L., Lok S.M., Yu I.M., Zhang Y., Kuhn R.J., Chen J., et al. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319 5871 (2008) 1830-1834